Tirupati Group

What Tirupati Group does

Tirupati Group is a pharmaceutical and nutraceutical Contract Development and Manufacturing Organization (CDMO) founded in 2005 and headquartered in New Delhi, India. The group provides end-to-end contract manufacturing, product development, and private label solutions across six business verticals: pharmaceuticals, therapeutics, nutraceuticals, Ayurveda, sports nutrition, and veterinary products, serving 350+ companies globally including 75+ reputed international clients. Operations span multi-location manufacturing facilities in Paonta Sahib (Himachal Pradesh) and Noida (Uttar Pradesh) with a dosage-form portfolio covering tablets, capsules, oral liquids, powders, nasal/ear/eye drops, creams, ointments, and oils, supported by annual capacity of 140+ Crore tablets, 345+ Crore capsules, and 35,900+ units of liquids and powders. The group's technology and regulatory infrastructure includes a DSIR-approved R&D centre (TRDC) for formulation development, regulatory affairs capability for ACTD/CTD/eCTD submissions, and 25+ international certifications including WHO GMP, US FDA registration, EU Certificate of Conformity, Health Canada, MFDS Korea, and AYUSH Premium Mark. The group operates through five entities: Tirupati Medicare Limited (parent), Tirupati Lifesciences, Tirupati Wellness, Newtramax Healthcare, and the recently acquired Surya Herbal Limited.

Tirupati operates a B2B contract manufacturing and private-label model, generating revenue through per-batch manufacturing fees, formulation development charges, and private-label supply agreements. Pricing is quote-based and varies by dosage form, volume, regulatory jurisdiction, and certification requirements. Distribution is sales-led with an export presence in 10+ countries including the Philippines, UAE, USA, Canada, Korea, China, EU nations, Nepal, Yemen, and Uganda. The company is family-controlled by the Goyal family and has received two rounds of private equity investment: $50M from Affirma Capital in 2019 and approximately $122.5M from Kotak Alternate Asset Managers in March 2025. Tirupati reached a 1000+ Crore INR revenue milestone by 2023, equivalent to approximately $120M USD, reflecting a reported trajectory from 300+ Crore INR (2014) to 500+ Crore INR (2018) to 1000+ Crore INR (2023).

Name

Tirupati Group

Legal name

TIRUPATI MEDICARE LIMITED

Website

https://tirupatigroup.co.in

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Tirupati Group is a pharmaceutical and nutraceutical CDMO founded in 2005, providing contract manufacturing, formulation development, and private label solutions across tablets, capsules, liquids, and topical dosage forms to 350+ healthcare companies globally from facilities in Himachal Pradesh and Noida, India.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• Pharmaceutical contract manufacturing
• Nutraceutical contract manufacturing
• CDMO services
• Ayurvedic manufacturing
• Private label manufacturing

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing: Manufacturing partner providing end-to-end support from concept development to commercial production for pharmaceutical, nutraceutical, Ayurveda, and wellness products. Revenue generated through manufacturing fees based on production volume and complexity.
2. Product Development Services: R&D and product development services including new formulations, stability testing, and product differentiation for partners seeking customized healthcare solutions.
3. Private Label Solutions: Manufacturing under partner brands with flexible solutions for different product formats including strips, blisters, sachets, pouches, tubes, jars, and roll-ons.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Tirupati Group is a Contract Development and Manufacturing Organization (CDMO) that provides end-to-end pharmaceutical and nutraceutical manufacturing services to healthcare brands. The company delivers integrated solutions spanning concept development, formulation R&D, regulatory support, and commercial-scale production across multiple dosage forms (tablets, capsules, oral liquids, powders, drops, creams, ointments, and oils) for pharmaceutical, nutraceutical, Ayurveda, sports nutrition, and veterinary segments. Services include contract manufacturing, product development, private label solutions, and commercial scale production for 350+ partner companies globally.

Product overview

Tirupati Group operates as a Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical and nutraceutical manufacturing services. The company offers end-to-end solutions from concept development to commercial production across six business verticals: Pharmaceuticals (contract manufacturing), Therapeutics, Nutraceuticals, Ayurveda, Sports Nutrition, and Veterinary products. The portfolio includes multiple dosage form capabilities (tablets, capsules, oral liquids, powders, drops, creams, ointments, oils) manufactured through five group companies: Tirupati Medicare Limited (pharmaceutical formulations), Tirupati Lifesciences Private Limited (nutraceuticals and wellness), Tirupati Wellness Private Limited (innovative nutraceuticals), Surya Herbal Limited (acquired Ayurvedic/herbal products), and Newtramax Healthcare. The company emphasizes integrated development and manufacturing with multi-dosage expertise, strong regulatory compliance systems, and scalable production capacity for domestic and global markets.

Differentiator

Problem solved

Functional benefit

Brands

• Surya Herbal: Ayurvedic and herbal product manufacturing brand acquired in 2024
• TRDC (Tirupati Research and Development Centre)

Products and services

• Pharmaceutical Contract Manufacturing End-to-end pharmaceutical contract manufacturing services from concept development to commercial production, serving as a CDMO partner for pharmaceutical brands.
• Therapeutics Contract Manufacturing Development and manufacturing of therapeutic products designed for reliability and scale, supporting pharmaceutical brand partners with generic and prescription medications.
• Nutraceutical Contract Manufacturing Science-backed nutraceutical solutions focused on preventive health and evolving lifestyle needs, manufactured at scale with NSF-GMP certified facilities for dietary supplement and functional food brands.
• Ayurveda Contract Manufacturing Ayurvedic and herbal product manufacturing combining traditional knowledge with modern processes, supported by AYUSH Premium Mark and Ayurvedic WHO GMP certifications for traditional medicine brands.
• Sports Nutrition Contract Manufacturing High-quality sports and performance nutrition formulations built for modern wellness and fitness brands, with flexible formats and rapid scale-up capabilities.
• Veterinary Contract Manufacturing Animal health products and veterinary solutions supporting animal health, productivity, and care through specialized manufacturing capabilities for veterinary and animal health brands.
• Pharmaceutical Product Development and R&D Services R&D and product development services including new formulations, stability testing, and product differentiation, supported by a DSIR-approved research facility for partners seeking customized healthcare solutions.
• Private Label Manufacturing Solutions Manufacturing under partner brands with flexible solutions across multiple product formats including strips, blisters, sachets, pouches, tubes, jars, and roll-ons, for healthcare and wellness brand owners.

Quantifiable outcome

• 350+ companies trust Tirupati for manufacturing and development
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Laurus Labs: Indian pharmaceutical company providing CDMO services in APIs and formulations, with growing finished dosage form capabilities comparable to Tirupati's multi-dosage manufacturing.
• Suven Pharmaceuticals: Hyderabad-based CRAMS (Contract Research and Manufacturing Services) company focused on niche API and intermediate development, comparable to Tirupati's CDMO positioning with global pharma clients.
• Syngene International: Bengaluru-based CRO/CDMO providing contract development and manufacturing services to global pharmaceutical and nutraceutical companies, comparable to Tirupati's integrated discovery-to-commercial offering.
• Neuland Laboratories: Indian API and CDMO company offering contract manufacturing services to global pharma, with overlapping capabilities in small-molecule drug substance and drug product manufacturing.
• Sai Life Sciences: Indian CDMO offering API and drug product development and manufacturing services to global pharma and biotech, with similar multi-dosage form capabilities and international regulatory footprint.
• Divis Laboratories: Leading Indian API manufacturer with growing CDMO presence serving global pharma, comparable scale of operations and international regulatory certifications.
• Piramal Pharma Solutions: Indian-headquartered CDMO offering integrated drug development and manufacturing services across solid orals, liquids, and injectables for global pharma partners, directly competing with Tirupati's contract manufacturing model.
• Granules India: Indian pharmaceutical manufacturer specializing in high-volume formulations including tablets, capsules, and APIs for global generics companies, comparable to Tirupati's high-capacity multi-dosage operations.

Emerging players

• Aurigene Pharmaceutical Services: Indian CDMO offering drug substance and drug product development services to global pharma and biotech, with growing capabilities overlapping with Tirupati's integrated CDMO offering.

Broad incumbents

• Jubilant Pharmova: Diversified Indian pharma player with significant CDMO segment offering sterile injectables, APIs, and radiopharmaceuticals, providing a broader benchmark against Tirupati's CDMO operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/tirupati_group

Compliance20 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tirupati Group